West to Participate in Upcoming Investor Conference
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST) announced its participation in the Bank of America Global Healthcare Conference in London, UK. The event is scheduled for September 18, 2024, at 9:55 AM BST. As a global leader in injectable drug administration solutions, West's presentation at this conference is significant for investors and industry watchers.
The company will provide a live audio webcast of the event, accessible through the 'Investors' section of West's official website. For those unable to attend or watch live, a replay will be available for approximately 90 days after the event. This presentation offers an opportunity for stakeholders to gain insights into West's current operations, future strategies, and position in the healthcare industry.
Positive
- None.
Negative
- None.
News Market Reaction – WST
In the trading session that priced this news, WST declined 1.45%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conference-302238758.html
SOURCE West Pharmaceutical Services, Inc.